Literature DB >> 24101938

Extremely increased serum carbohydrate antigen 19-9 levels caused by new or resistant infections to previous antibiotics in chronic lung diseases.

Ji Young Shin1, Su Jin Yoo, Bo Mi Park, Sung Su Jung, Ju Ock Kim, Jeong Eun Lee.   

Abstract

In this paper, we describe 72-year-old female patient without evidence of malignant disease presented with significantly elevated serum carbohydrate antigen (CA) 19-9 levels by respiratory infections. She was diagnosed with respiratory infections due to Mycobacterium avium complex and Pseudomonas aeruginosa. The serum CA 19-9 levels remarkably increased (1,453-5,300 U/mL; reference range, <37 U/mL) by respiratory infection and abruptly decreased (357-534 U/mL) whenever infection was controlled by specific treatments. This case suggests that serum CA 19-9 levels may be used as a diagnostic marker to indicate new or resistant infections to previous antibiotics in chronic lung diseases without significant changes in chest X-ray findings.

Entities:  

Keywords:  CA19-9 Antigen; Infection; Lung Neoplasms

Year:  2013        PMID: 24101938      PMCID: PMC3790025          DOI: 10.4046/trd.2013.75.3.125

Source DB:  PubMed          Journal:  Tuberc Respir Dis (Seoul)        ISSN: 1738-3536


  11 in total

1.  Characteristics of pulmonary Mycobacterium avium-intracellulare complex (MAC) infection in comparison with those of tuberculosis.

Authors:  K Watanabe; M Fujimura; K Kasahara; M Yasui; S Myou; A Watanabe; S Nakao
Journal:  Respir Med       Date:  2003-06       Impact factor: 3.415

2.  Extremely elevated CA19-9 in acute cholangitis.

Authors:  Shyr-Ming Sheen-Chen; Cheuk-Kwan Sun; Yei-Wei Liu; Hock-Liew Eng; Sheung-Fat Ko; Chung-Huang Kuo
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

3.  [A study of sialylated carbohydrate antigen in patients with benign bronchopulmonary disease].

Authors:  T Yokoyama; Y Ikedou; F Kido; S Tanoue; K Tashiro; H Ninomiya; T Rikimaru; A Kajiki; M Takamoto; T Ishibashi; K Oizumi
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  1998-10

4.  Mirizzi's syndrome with a high CA19-9 level mimicking cholangiocarcinoma.

Authors:  C L Lin; C S Changchien; Y S Chen
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

5.  Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection.

Authors:  Y Yamazaki; K Kubo; A Takamizawa; H Yamamoto; T Honda; S Sone
Journal:  Am J Respir Crit Care Med       Date:  1999-12       Impact factor: 21.405

6.  Serum levels of CA19-9 in patients with nonmalignant respiratory diseases.

Authors:  Takahide Kodama; Hiroaki Satoh; Hiroichi Ishikawa; Morio Ohtsuka
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Increased CA 19-9 level in patients without malignant disease.

Authors:  Hye-Ryoun Kim; Chang-Hyun Lee; Young Whan Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

8.  Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen.

Authors:  Y Matsuoka; K Endo; Y Kawamura; T Yoshida; T Saga; Y Watanabe; M Koizumi; T Nakashima; J Konishi; N Yamaguchi
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

9.  Colocalization of CA19-9 and KL-6 to epithelial cells in dilated bronchioles in a patient with idiopathic pulmonary fibrosis complicated by diffuse alveolar damage.

Authors:  Yuji Shimizu; Tetsuya Hamada; Yoshiki Tanaka; Atsushi Sasaki; Toshikazu Nemoto
Journal:  Respirology       Date:  2002-09       Impact factor: 6.424

Review 10.  Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art.

Authors:  M Plebani; D Basso; M P Panozzo; P Fogar; G Del Favero; R Naccarato
Journal:  Int J Biol Markers       Date:  1995 Oct-Dec       Impact factor: 3.248

View more
  3 in total

1.  Chronic bronchitis with fungal infection presenting with marked elevation of serum carbohydrate antigen 19-9: a case report.

Authors:  Ping Han; Wei Yan; Yi Luo; Wei Tu; Jia-Yi He; Jing-Mei Liu; Jin Gong; Yun-Wu Wang; Meng-Ke Li; De-An Tian; Huan-Jun Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

2.  Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer.

Authors:  Zhong-Qing Chen; Ling-Sha Huang; Bo Zhu
Journal:  Dis Markers       Date:  2018-12-11       Impact factor: 3.434

3.  Elevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease.

Authors:  Ji Young Hong; Sun Hee Jang; Song Yee Kim; Kyung Soo Chung; Joo Han Song; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Young Ae Kang
Journal:  Braz J Infect Dis       Date:  2015-11-22       Impact factor: 3.257

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.